Curcumin
January 15, 2020
Fisetin
January 15, 2020
EF24 (Tumeric Root)
- A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies
- Abstract P4-16-02: EF24 targets radiation-induced NFkB-dependent stemness in triple negative breast cancer cells
- Activation of the p38 pathway by a novel monoketone curcumin analog, EF24, suggests a potential combination strategy
- Analysis of the EF24-modulated signaling pathways for the development of novel cancer combination therapies
- Antibacterial activity of synthetic curcumin derivatives: 3, 5-bis (benzylidene)-4-piperidone (EF24) and EF24-dimer linked via diethylenetriaminepentacetic acid (EF 2 …
- Anti-Cancer and Ototoxicity Characteristics of the Curcuminoids, CLEFMA and EF24, in Combination with Cisplatin
- Anticancer mechanism and application of curcumin analog EF24
- Anti-HIF Activity of curcumin and analog EF24.
- Anti-inflammatory mediators ST2 and SIGIRR are induced by diphenyldifluoroketone EF24 in lipopolysaccharide-stimulated dendritic cells
- Bioactivities of EF24, a novel curcumin analog: A review
- Biological Effects of EF24, a Curcumin Derivative, Alone or Combined with Mitotane in Adrenocortical Tumor Cell Lines
- Cerebral bioenergetics in hypovolemic shock: Mechanistic insights into the efficacy of EF24.
- Curcumin analog EF24 induces apoptosis and downregulates the mitogen activated protein kinase/extracellular signal-regulated signaling pathway in oral squamous …
- Curcumin analog EF24 induces apoptosis via ROS-dependent mitochondrial dysfunction in human colorectal cancer cells
- Curcuminoid EF24 enhances the anti‐tumour activity of Akt inhibitor MK‐2206 through ROS‐mediated endoplasmic reticulum stress and mitochondrial dysfunction in …
- Design, synthesis, and biological evaluation of novel EF24 and EF31 analogs as potential IκB kinase β inhibitors for the treatment of pancreatic cancer
- Design, synthesis, and evaluation of asymmetric EF24 analogues as potential anti-cancer agents for lung cancer
- Diphenyldifluoroketone EF24 Suppresses Pro-inflammatory Interleukin-1 receptor 1 and Toll-like Receptor 4 in lipopolysaccharide-stimulated dendritic cells
- Diphenyldihaloketones CLEFMA and EF24 target RPN13 for pharmacotherapy of gut barrier dysfunction in hemorrhagic shock
- EF24 (a curcumin analog) and ZSTK474 emphasize the effect of cabozantinib in medullary thyroid cancer
- EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects …
- EF24 attenuates radiation-regulated eNOS→ NO-dependent NFκB-mediated matrix metalloproteinases in human neuroblastoma
- EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression
- EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by inhibiting proteasomal degradation of pten
- EF24 induces ROS-mediated apoptosis via targeting thioredoxin reductase 1 in gastric cancer cells
- EF24 inhibits tumor growth and metastasis via suppressing NF-kappaB dependent pathways in human cholangiocarcinoma
- EF24 prevents rotenone‐induced estrogenic status alteration in breast cancer
- EF24 Suppresses Cholangiocellular Carcinoma Progression, Inhibits STAT3 Phosphorylation, and Induces Apoptosis via ROS-Mediated Oxidative Stress
- EF24 suppresses invasion and migration of hepatocellular carcinoma cells in vitro via inhibiting the phosphorylation of Src
- EF24 suppresses maturation and inflammatory response in dendritic cells
- EF24, a novel curcumin analog, disrupts the microtubule cytoskeleton and inhibits HIF-1
- EF24, a novel curcumin analogue inhibits oncogenic activation induced by radiation abscopal effect in distant mice lungs
- EF24, a novel synthetic curcumin analog, induces apoptosis in cancer cells via a redox-dependent mechanism
- Effects of a Curcumin Analog, EF24, on Reproductive Function in Rats.
- Evaluation of the High Mobility Group A1 proteins (HMGA1) as a key mediate in the anticancer activity of-EF24.
- Evaluation of the Potential HMGA1-EF24 Nexus in Human Colon Cancer
- Fluoro and pentafluorothio analogs of the antitumoral curcuminoid EF24 with superior antiangiogenic and vascular-disruptive effects
- HDAC inhibitors, MS-275 and salermide, potentiates the anticancer effect of EF24 in human pancreatic cancer cells
- Hemorrhagic shock-induced cerebral bioenergetic imbalance is corrected by pharmacologic treatment with EF24 in a rat model
- Hypoxia‐mediated sorafenib resistance can be overcome by EF24 through Von Hippel‐Lindau tumor suppressor‐dependent HIF‐1α inhibition in hepatocellular …
- Impressive suppression of colon cancer growth by triple combination SN38/EF24/melatonin:“
oncogenic” versus “onco-suppressive” reactive oxygen species - In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog
- Induction of gut proteasome activity in hemorrhagic shock and its recovery by treatment with diphenyldihaloketones CLEFMA and EF24
- Inhibition of IκB kinase-nuclear factor-κB signaling pathway by 3, 5-bis (2-flurobenzylidene) piperidin-4-one (EF24), a novel monoketone analog of curcumin
- Liposome-encapsulated EF24-HPβCD inclusion complex: a preformulation study and biodistribution in a rat model
- MicroRNA-33b, upregulated by EF24, a curcumin analog, suppresses the epithelial-to-mesenchymal transition (EMT) and migratory potential of melanoma cells by …
- Multiple anticancer activities of EF24, a novel curcumin analog, on human ovarian carcinoma cells
- Pharmacologic suppression of inflammation by a diphenyldifluoroketone, EF24, in a rat model of fixed-volume hemorrhage improves survival
- Radiosensitization of glioma cells with the curcumin analogs EF24 and EF31
- Remediation of hemorrhagic shock-induced intestinal barrier dysfunction by treatment with diphenyldihaloketones EF24 and CLEFMA
- Study on the relationship between autophagy and apoptosis in A549 cells induced by curcumin analogue EF24
- Synergistic anticancer potential of the combination of the novel curcumin analog EF24 and p38 MAPK inhibitors
- Synergistic antitumor activity of rapamycin and EF24 via increasing ROS for the treatment of gastric cancer
- Synthesis and anti-tumor activity of EF24 analogues as IKKβ inhibitors
- Synthesis of EF24− tripeptide chloromethyl ketone: a novel curcumin-related anticancer drug delivery system
- Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa
- The curcumin analog EF24 is a novel senolytic agent
- The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo
- The impact of curcumin analogs EF24 on HepG2 and the development of zebra fish embryo [J]
- The salutary effects of diphenyldifluoroketone EF24 in liver of a rat hemorrhagic shock model
- Ubiquitin Receptor RPN13 Mediates the Inhibitory Interaction of Diphenyldihaloketones CLEFMA and EF24 with the 26S Proteasome
